Skip to main content
Type at least 3 characters

713 articles

Study Protocol

Accepted on 10 Apr 2025

A multi-center, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of Fuzheng Yangxin Prescription in treating heart failure with preserved ejection fraction (Qi-Yin deficiency and blood stasis syndrome): Study Protocol

in Heart Failure and Transplantation

  • Jingjing Chen
  • Zian Yan
  • Jiacong Wang
  • Lijun Guo
  • Zhonghui Jiang
  • Fangfang Wang
  • Ruina Bai
  • Xiaochang Ma
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1514181
  • 101 views

Perspective

Published on 28 Mar 2025

National strategy for integrating palliative care into standard cardiac care for people living with heart failure: a position statement from the joint working group of the Swiss Societies of Cardiology and Palliative Care

in Heart Failure and Transplantation

  • Piotr Z. Sobanski
  • Maria Luisa De Perna
  • Sandra Eckstein
  • Tanja Fusi-Schmidhauser
  • Jan Gaertner
  • Valentina Gonzalez-Jaramillo
  • Lisa Hentsch
  • Caroline Hertler
  • Roger Hullin
  • Lukas Hunziker
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1548595
  • 927 views

Original Research

Accepted on 18 Mar 2025

Effectiveness and safety of rivaroxaban in patients with atrial fibrillation and heart failure in clinical practice: an indirect comparison of national and international registries

in Heart Failure and Transplantation

  • Jose Maria Cepeda
  • Nicolas Manito
  • Alejandro Recio Mayoral
  • Iñaki Lekuona
  • Miguel Castillo Orive
  • Elvira Blanco Labrador
  • MarĂ­a Teresa Blasco
  • Nuria FarrĂ©
  • JosĂ© Manuel GarcĂ­a Pinilla
  • Javier JimĂ©nez-Candil
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2025.1451499